Psoriatic arthritis: epidemiology, clinical features, course, and outcome
2005/02/11 by D D Gladman, Dafna D. Gladman, Christian Antoni +7 · 31 citations
Medicine · Immunology and Microbiology · #Spondyloarthritis Studies and Treatments #Psoriasis: Treatment and Pathogenesis #Rheumatoid Arthritis Research and Therapies
paper · pdf · doi:10.1136/ard.2004.032482
Cited by
- Obesity in Early Adulthood as a Risk Factor for Psoriatic Arthritis
- Psoriasis in the US Medicare Population: Prevalence, Treatment, and Factors Associated with Biologic Use
- Longterm (52-week) Results of a Phase III Randomized, Controlled Trial of Apremilast in Patients with Psoriatic Arthritis
- Inflammatory protein profiling in immune cells identifies molecular signatures for enhanced diagnostic precision in psoriatic arthritis
- Physical fitness and physical activity in psoriatic arthritis: a systematic review
- Toward Harmonized Recommendations for Psoriatic Arthritis: A Comparative Viewpoint on Global Guidelines
- A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes. [europepmc]
- Incidence and clinical predictors of psoriatic arthritis in patients with psoriasis: a population-based study. [europepmc]
- New insights into the pathogenesis and genetics of psoriatic arthritis. [europepmc]
- Progress in spondylarthritis. Mechanisms of new bone formation in spondyloarthritis. [europepmc]
- Genome-wide meta-analysis of psoriatic arthritis identifies susceptibility locus at REL. [europepmc]
- Validity of diagnostic codes and prevalence of psoriasis and psoriatic arthritis in a managed care population, 1996-2009. [europepmc]
- Higher rates and clustering of abnormal lipids, obesity, and diabetes mellitus in psoriatic arthritis compared with rheumatoid arthritis. [europepmc]
- The IL-23/IL-17 axis in psoriatic arthritis. [europepmc]
- Dense genotyping of immune-related susceptibility loci reveals new insights into the genetics of psoriatic arthritis. [europepmc]
- A comparison of disease burden in rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis. [europepmc]
- Psoriasis in the US Medicare Population: Prevalence, Treatment, and Factors Associated with Biologic Use. [europepmc]
- Effect of tight control of inflammation in early psoriatic arthritis (TICOPA): a UK multicentre, open-label, randomised controlled trial. [europepmc]
- Apremilast, an oral phosphodiesterase 4 inhibitor, in patients with psoriatic arthritis and current skin involvement: a phase III, randomised, controlled trial (PALACE 3). [europepmc]
- Ixekizumab, an interleukin-17A specific monoclonal antibody, for the treatment of biologic-naive patients with active psoriatic arthritis: results from the 24-week randomised, double-blind, placebo-controlled and active (adalimumab)-controlled period of the phase III trial SPIRIT-P1. [europepmc]
- Autophagy and autoimmunity. [europepmc]
- Efficacy and safety of abatacept, a T-cell modulator, in a randomised, double-blind, placebo-controlled, phase III study in psoriatic arthritis. [europepmc]
- Secukinumab improves active psoriatic arthritis symptoms and inhibits radiographic progression: primary results from the randomised, double-blind, phase III FUTURE 5 study. [europepmc]
- Cartilage diseases. [europepmc]
- The Therapeutic and Pathogenic Role of Autophagy in Autoimmune Diseases. [europepmc]
- A head-to-head comparison of the efficacy and safety of ixekizumab and adalimumab in biological-naïve patients with active psoriatic arthritis: 24-week results of a randomised, open-label, blinded-assessor trial. [europepmc]
- Pharmacomicrobiomics in inflammatory arthritis: gut microbiome as modulator of therapeutic response. [europepmc]
- Pathogenesis of Chronic Plaque Psoriasis and Its Intersection With Cardio-Metabolic Comorbidities. [europepmc]
- Brodalumab in psoriatic arthritis: results from the randomised phase III AMVISION-1 and AMVISION-2 trials. [europepmc]
- Interleukin-17 and Interleukin-23: A Narrative Review of Mechanisms of Action in Psoriasis and Associated Comorbidities. [europepmc]
- Lyme arthritis: linking infection, inflammation and autoimmunity. [europepmc]